Kite Pharma
The Senior Manager, Regulatory Affairs CMC supports and drives complex CMC regulatory activities for Kite’s cell therapy and CAR-T portfolio across clinical and commercial development. This role contributes to global regulatory strategies, prepares CMC submissions, and partners with cross-functional teams to ensure timely, compliant deliverables throughout the product lifecycle. The position involves managing vector-related changes, manufacturing network expansion, and inspection readiness while operating with considerable independence.
Headquarters
Santa Monica, California, United States
Company Size
1001-5000 employees
Founded
2009
Kite Pharma is a biotechnology company focused on developing cell therapies to treat cancer, specializing in engineered T‑cell (CAR‑T) approaches. The company advances programs from basic science through clinical trials and commercialization, maintaining an active pipeline of therapies for hematologic and solid tumors. Kite also provides patient resources, treatment center networks, and access programs to support therapy delivery. It operates as part of Gilead Sciences, leveraging global capabilities to accelerate curative cancer treatments.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Kite Pharma.
6% above the average for this role